Mavridou Konstantina, Gavriil Sofia, Papoudou-Bai Alexandra, Gaitanis George, Piperidou Alexia, Bassukas Ioannis D
Department of Dermatology, University Hospital of Ioannina.
Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Ioannina.
Dermatol Reports. 2025 Feb 6;17(1). doi: 10.4081/dr.2024.10013. Epub 2024 Oct 15.
Isolated cutaneous myeloid sarcoma (icMS) and aleukemic leukemia cutis (ALC) are cutaneous extramedullary manifestations of leukemia in which leukemic cells infiltrate the skin before they can be identified either in the peripheral blood or in the bone marrow. We report the case of a 67-year-old patient who presented with a rapidly developing cutaneous tumor and scaly, erythematous- squamous plaques. Isolated cutaneous myeloid sarcoma was diagnosed, which rapidly progressed to terminal-stage acute myeloid leukemia (AML). To highlight the disease characteristics of the adult-onset icMS and ALC cases that preceded AML, we additionally compiled the pertinent literature of case reports of these rare conditions. We identified 15 previously published icMS/ALC cases with adequately detailed clinical data descriptions. We could confirm medical experience that icMS/ALC patients have a worse overall prognosis. Moreover, we could identify FAB-M5 AML subtype as a significant adverse prognosticator in these patients.
孤立性皮肤髓系肉瘤(icMS)和无白血病性白血病皮肤浸润(ALC)是白血病的皮肤髓外表现,其中白血病细胞在可在外周血或骨髓中被识别之前就浸润皮肤。我们报告了一例67岁患者,其出现迅速发展的皮肤肿瘤以及鳞屑性、红斑鳞状斑块。诊断为孤立性皮肤髓系肉瘤,该疾病迅速进展为终末期急性髓系白血病(AML)。为突出AML之前发生的成人型icMS和ALC病例的疾病特征,我们还汇编了这些罕见病症的病例报告相关文献。我们确定了15例先前发表的icMS/ALC病例,其具有充分详细的临床数据描述。我们可以证实临床经验,即icMS/ALC患者的总体预后较差。此外,我们可以确定FAB-M5 AML亚型是这些患者的一个显著不良预后因素。